Clinical and Experimental Ophthalmology

Article	Citations
Continuing Professional Development	220
Past Lecturers and Briefs For the Named Lectures: RANZCO Annual Scientific Congress	101
Issue Information	91
Issue Information	72
Mimickers of hydroxychloroquine retinal toxicity	65
Stromal Curvature, Power and Corneal‐Stromal Curvature Ratios From a Hybrid AS‐OCT in Eyes With Keratoconus	63
The Long Journey of Treatment for Wet Macular Degeneration, Is It Worth It?	62
The association between keratoconus and allergic eye diseases: A systematic review and meta‐analysis	56
Fluid misdirection syndrome associated with endothelial keratoplasty: A multicenter case series	46
Recent advances in the use of optical coherence tomography in neuro‐ophthalmology: A review	43
Proposal of a Simpler Eye‐Level Risk Model Incorporating Reticular Pseudodrusen for the Clinical Prediction of Late Age‐Related Macular Degeneration	40
Circular RNA expression profile and functional analysis of circUvrag in light‐induced photoreceptor degeneration	40
Improved methods for isolating the mouse retinal vasculature	39
Genetics in neovascular age‐related macular degeneration susceptibility and treatment response to anti‐VEGF intravitreal injection: A case series study	38
Telemedicine and delivery of ophthalmic care in rural and remote communities: Drawing from Australian experience	36
Issue Information	35
Bevacizumab biosimilar (bevacizumab‐awwb) is safe in the treatment of retinopathy of prematurity	32
Continuing Professional Development	26
	25
Sunday 27 February Speakers	23
Continuing Professional Development	22
Issue Information	22
Publishing opportunities and gender equity: Embedding monitoring in eye health education	21
Optimised minus lens overcorrection for paediatric intermittent exotropia: A randomised clinical trial	21
‘Closing the gap’ on visual acuity outcomes of Indigenous and remote patients receiving intravitreal injections in Northern Australia	21

Continuing Professional Development	21
Anti‐vascular endothelial growth factor for neovascular age‐related macular degeneration in 2022: Same, same but different	20
Global challenges in the management of diabetic retinopathy in women with pre‐gestational diabetes	20
	20
Is it time to consider how we approach bilateral same‐day cataract surgery?	20
Comparison of various treatment modalities in patients with primary vitreoretinal lymphoma: A systematic review and meta‐analysis	19
Social determinants of health and health disparities in glaucoma: A review	19
Suprachoroidal steroids for uveitic macular oedema: Teaching an old drug new tricks?	18
Gender differences in retinal diseases: A review	18
Topical Dorzolamide for Macular Holes: A Randomised, Double‐Blind, Placebo‐Controlled Trial–Comment	18
Management of macular oedema due to retinal vein occlusion: An evidence‐based systematic review and meta‐analysis	18
Issue Information	18
	18
Long‐term limitations and complications of trans‐scleral diode laser cycloablation for refractory glaucoma	17
Issue Information	17
Chronic Kidney Disease and Glaucoma: Is the Case Truly Closed?	17
Seasonal Variation in HLA‐B27 Associated Uveitis	16
Comparison of metabolic profiles in aqueous humour of Fuchs' syndrome and presumed viral‐induced anterior uveitis patients	16
Optimising the Evaluation of Optic Neuritis YouTube Videos: A Call for Multimedia‐Specific Tools and Audience‐Oriented Approaches—Response	16
Bridging healthcare disparities in diabetic retinopathy care: Insights from Sri Lanka	16
Seasonal Trends in HLA‐B27‐Associated Uveitis: A Commentary on Recent Findings	16
	15
Corneal endothelial evaluations in immunoglobulin g4‐related ophthalmic disease	15
Randomised controlled trial on robot‐assisted versus manual surgery for pucker peeling	14
Prediction of refraction error after toric lens implantation with biometric input data uncertainties and power labelling tolerances	14
Evaluation of ChatGPT‐4 responses to glaucoma patients' questions: Can artificial intelligence become a trusted advisor between doctor and patient?	13
Comparative study of 2‐year outcomes for Hydrus or iStent inject microinvasive glaucoma surgery implants with cataract surgery	13
Environmental influences on ophthalmic conditions: A scoping review	13
Myopia progression following 0.01% atropine cessation in Australian children: Findings from the Western Australia – Atropine for the Treatment of Myopia (WA‐ATOM) study	13
Scientific Program	12
Insights into the diagnosis and management of sarcoid uveitis: A review	12
Corrigendum	12
	12
Australian Pharmaceutical Benefits scheme data on utilisation of intravitreal therapy in retinal vein occlusion	12
Monday 28 February Speakers	12
Antimicrobial stewardship in ocular infections: Fourteen years of over‐the‐counter chloramphenicol in Australia	12
Dr AI will see you now	12
Keratoconus in Down syndrome: Prevalence, risk factors, severity and corneal tomographic characteristics	11
Preventing Shunt Launch: A Novel Technique for Extraocular Flushing of the PreserFlo MicroShunt	11
Are There Biomechanical Changes in Tomographically Progressive Keratoconus Corneas?	11
Correction to ‘Prediction of refraction error after toric lens implantation with biometric input data uncertainties and power labelling tolerance’	11
Leber Hereditary Optic Neuropathy: Support, Genetic Prediction and Accurate Genetic Counselling Enhance Family Planning Choices	11
A Chat About Peer Review	11
Predictive Factors for Uveitis Refractory to Treatment in Initial‐Onset Acute Vogt‐Koyanagi‐Harada Disease	11
Biometry and corneal aberrations after cataract surgery in childhood	11
AI: From productivity dividend to better patient outcome	10
Retraction	10
Central serous chorioretinopathy: A review	10
Saturday 29 October Speakers	10
Issue Information	10

Issue Information	10
Saturday 02 November	10
Te hauora karu o te iwi Māori: A comprehensive review of Māori eye health in Aotearoa/New Zealand	9
Evaluation of ocular surface following PreserFlo Microshunt implantation: Functional outcomes and quality of life	9
Outcomes of cataract surgery in paediatric uveitis: A multisite study	9
Nocturnal hypoxia and age‐related macular degeneration	9
Evaluation of mild periorbital cellulitis and home‐based therapy in children—EPOCH study: A prospective single centre cohort study	9
Investigation of epidemiological characteristics and development of a nomogram to predict survival in primary ocular adnexal lymphoma	9
Epidemiology of monocanalicular stenting in paediatric lacrimal canalicular trauma	9
Utility of topical cocaine testing for the evaluation of paediatric anisocoria	8
Longitudinal Visual Biomarkers in Dominant Optic Atrophy: A Systematic Review and Meta‐Analysis	8
Biomarkers in age‐related macular degeneration	8
Diagnostic Ability of Transverse Axial Images Obtained by Optical Coherence Tomography for Detecting Anterior Displacement of Peripapillary Tissues in Papilledema	8
Retreatment interval lengthening achieved in two thirds of eyes with prolonged intensive anti‐VEGF therapy for neovascular age‐related macular degeneration after switching to faricimab	8
Issue Information	8
Outcomes of Stent Removal in Eyes With the Paul Glaucoma Implant With Intraluminal 6–0 Polypropylene	8
Global retinoblastoma studies: A review	8
Evaluation of moderate periorbital cellulitis and home‐based therapy in children (EPOCH study, Part 2): A prospective single centre cohort study	7
Utilisation of Genetic Testing of Inherited Retinal Diseases in an Australian Public Tertiary Hospital Setting	7
Impact of glucagon‐like peptide‐1 receptor agonists on diabetic retinopathy: A meta‐analysis of clinical studies emphasising retinal changes as a primary outcome	7
Safety of an Intravitreal Bevacizumab Biosimilar (MVASI)	7
Retinal Gene Therapy: Perceptions of Ophthalmologists in Australia and New Zealand	7
Current understanding of subclinical diabetic retinopathy informed by histology and high‐resolution in vivo imaging	7
Issue Information	7
Normal‐tension glaucoma: Current concepts and approaches‐A review	7
Eyes Offshore: Reporting the Eye Health Needs of Refugees and Asylum Seekers in Australia's Offshore Detention Centres	6
Poster Abstracts	6
Continuing Professional Development	6
Natural history and biomarkers of KCNV2‐associated retinopathy	6
Diabetic Retinopathy During Pregnancy: Implications of Intensive Control Prior to Pregnancy With Incretin Mimetic Therapy in Type 2 Diabetes Mellitus	6
Detecting Glaucoma in Highly Myopic Eyes From Fundus Photographs Using Deep Convolutional Neural Networks	6
Continuing professional development	6
Seeking best outcomes for patients living with vitreoretinal lymphoma	6
Ageing and retinal thickness: An important association	6
Low‐concentration atropine eyedrops for myopia control in a multi‐racial cohort of Australian children: A randomised clinical trial	6
Prediction of refraction error after toric lens implantation with biometric input data uncertainties and power labelling tolerances: Response	6
Evaluation of artificial intelligence models for the detection of asymmetric keratoconus eyes using Scheimpflug tomography	6
A retinal endothelial cell barrier is disrupted by direct contact with retinal Müller glial cells in vitro	6
Reliability of surgical memory and self‐report in patients with prior strabismus surgery	6
One‐year real‐world outcomes of bevacizumab for the treatment of macular oedema secondary to retinal vein occlusion	6
Predictability of success for combined iStent inject trabecular bypass implantation with phacoemulsification in the subsequent eye	6
Past Lecturers and Briefs for the Named Lectures: RANZCO Annual Scientific Congress	5
Film Abstracts	5
Running to save sight: The effects of exercise on retinal health and function	5
Effect of lens status and age on ultra‐wide‐field fundus autofluorescence in eyes with granular corneal dystrophy	5
A focus on glaucoma	5
The enigma of corneal astigmatism	5
Optic nerve sheath fenestration for treating papilloedema in the era of cerebral venous sinus stenting	5
Medical therapy for glaucoma: A review	5
The challenge in the diagnosis and management of vitreoretinal lymphoma	5
Use of antihypertensive medications and the risk of glaucoma onset: Findings from the 45 and Up Study	5
CONTINUING PROFESSIONAL DEVELOPMENT	5
Issue Information	5
Reactivation of stable neovascular age‐related macular degeneration following treat‐and‐extend regimen discontinuation	5
The Challenge of Managing Paediatric Periorbital Cellulitis	5
	5
Comparison of intraocular pressure and anterior segment parameters in subjects with asymmetrical primary angle closure disease	5
Issue Information	5
Association between dietary niacin and retinal nerve fibre layer thickness in healthy eyes of different ages	5
Evidence on the Use of Topical Ciclosporin for Ocular Surface Disease: A Systematic Review and Meta‐Analysis—Response	5
An old yet new issue: Infection of the eye	5
Invited Speakers	5
Topical dorzolamide for macular holes: A randomised, double‐blind, placebo‐controlled trial	5
Real‐world outcomes of low‐dose atropine therapy on myopia progression in an Australian cohort during the COVID‐19 pandemic	5
Powerful predictors	5
Continuing Professional Development	5
Film Abstracts	5
Continuing Professional Development	5
Deep learning in optical coherence tomography: Where are the gaps?	5
	5
Optic nerve diseases and regeneration: How far are we from the promised land?	4
Assessing the carbon footprint of fluorinated gases in vitreoretinal surgery	4
Utilisation of patient‐centred outcome measures in age‐related macular degeneration research and clinical practice: A systematic review	4
The Royal Australian and New Zealand College of Ophthalmologists, 55th Annual Scientific Congress 1 – 4 November 2024Adelaide Convention Centre	4
Sustained and rebound effect of repeated low‐level red‐light therapy on myopia control: A 2‐year post‐trial follow‐up study	4
Efficacy of oral doxycycline in the treatment of recurrent corneal erosion syndrome	4
A novel genomic rearrangement on chr19q13.42 leads to PRPF31‐associated retinitis pigmentosa	4
Uveitis masquerade syndromes: An approach to diagnosis	4
Optimising Paul Glaucoma Implant Stent Management: Prophylactic Aqueous Suppression, Telemetric IOP Monitoring, and Microfluidic Insights	4
Continuing Professional Development	4

Risk factors associated with XEN gel stent‐related endophthalmitis	4
	4
Retention time of different ophthalmic viscosurgical devices during phacoemulsification in rabbit ocular model: A comparative analysis	4
Invited Speakers	4
Preclinical biocompatibility and biosafety evaluation of a new foldable brown diaphragm intraocular lens: An in vitro and in vivo study	4
Quantification of localised vascular wedge‐shaped defects in glaucoma	4
Clinical outcomes of fiducial‐free proton beam therapy in Asian patients with uveal melanoma	4
Posterior involvement in fencing wire open globe injuries	4
Body mass index and astigmatism: A nationwide study	4
Continuing professional development	4
Association of obesity and metabolic syndrome with incident primary open angle glaucoma in the UK Biobank	4
Visual fields in glaucoma: Where are we now?	4
Should this artificial intelligence algorithm be used in my practice now? A checklist approach: Response	4